Development of a reference system for the international standardization of HbA1c/glycohemoglobin determinations

W Hoelzel1, K Miedema

  • 1R&D Laboratory Systems Boehringer Mannheim Diagnostics, Tutzing, Germany.

Journal of the International Federation of Clinical Chemistry
|May 7, 1996
PubMed

Insights

International standardization of glycohemoglobin (HbA1c) measurements is crucial for accurate diabetes care due to poor method comparability. The IFCC is developing a reference system to standardize all glycohemoglobin assays globally.

Area of Science:

  • Clinical Chemistry
  • Laboratory Medicine
  • Diabetes Mellitus Research

Background:

  • Glycohemoglobin (HbA1c) measurements are vital for diabetes management.
  • Current methods show poor comparability between clinical laboratories.
  • This variability hinders accurate patient monitoring and treatment.

Purpose of the Study:

  • To address the critical need for international standardization of glycohemoglobin assays.
  • To establish a unified reference system for consistent HbA1c testing worldwide.
  • To improve the reliability and comparability of diabetes diagnostic results.

Main Methods:

  • Development of a reference system by the IFCC working group on HbA1c standardization.
  • Focus on HbA1c as the primary, biochemically defined glycohemoglobin.
  • Inclusion of primary and secondary reference materials, a reference method, and adjusted values.

Main Results:

  • The IFCC is establishing a comprehensive reference system for HbA1c standardization.
  • This system aims to ensure consistency across different laboratory methods.
  • The goal is to provide a basis for harmonizing glycohemoglobin measurements globally.

Conclusions:

  • A robust international standardization system for glycohemoglobin is essential.
  • The IFCC's reference system will enhance the accuracy and comparability of diabetes care.
  • This initiative will ultimately benefit patients through more reliable diagnostic testing.